Published in Ann Intern Med on December 04, 2001
The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause (2012) 4.04
Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS (2008) 3.66
Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med (2004) 3.12
Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS (2005) 3.07
Ambient air pollution and the progression of atherosclerosis in adults. PLoS One (2010) 2.53
Vascular actions of estrogens: functional implications. Pharmacol Rev (2008) 2.52
Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis (2012) 2.16
Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J Gen Intern Med (2006) 1.76
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause (2008) 1.74
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial. Stroke (2008) 1.67
Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. N Engl J Med (2016) 1.66
T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis (2011) 1.64
Risks and benefits of hormone replacement therapy: the evidence speaks. CMAJ (2003) 1.63
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
Hormone therapy and risk of cardiovascular outcomes and mortality in women treated with statins. Menopause (2015) 1.45
Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke (2010) 1.44
Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab (2007) 1.38
Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment. J Acquir Immune Defic Syndr (2012) 1.37
Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection. AIDS (2013) 1.23
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. Arterioscler Thromb Vasc Biol (2012) 1.22
Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial. Stroke (2011) 1.18
Vitamin D levels and markers of arterial dysfunction in HIV. AIDS Res Hum Retroviruses (2011) 1.12
Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. J Cardiovasc Transl Res (2011) 1.11
Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev (2005) 1.10
Persistence of the metabolic syndrome and its influence on carotid artery intima media thickness in overweight Latino children. Atherosclerosis (2009) 1.07
Components of air pollution and cognitive function in middle-aged and older adults in Los Angeles. Neurotoxicology (2013) 1.04
Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels. Curr Med Chem (2009) 1.01
Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study. Atherosclerosis (2012) 1.01
Sex/gender medicine. The biological basis for personalized care in cardiovascular medicine. Circ J (2009) 1.01
Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study. AIDS (2009) 0.99
Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis. Menopause (2015) 0.98
Circulating microparticles and endogenous estrogen in newly menopausal women. Climacteric (2009) 0.98
Estrogen decreases atherosclerosis in part by reducing hepatic acyl-CoA:cholesterol acyltransferase 2 (ACAT2) in monkeys. Arterioscler Thromb Vasc Biol (2009) 0.97
A "window of opportunity:" the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent. Brain Res (2010) 0.96
Relation of Framingham risk score to subclinical atherosclerosis evaluated across three arterial sites. Am J Cardiol (2008) 0.95
Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study. Breast Cancer Res (2005) 0.94
Postmenopausal hormone therapy: risks and benefits. Nat Rev Endocrinol (2013) 0.93
Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics (2012) 0.93
HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis. Clin Infect Dis (2015) 0.93
Postmenopausal hormone therapy and cardiovascular disease in perspective. Clin Obstet Gynecol (2008) 0.92
Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women. Arterioscler Thromb Vasc Biol (2005) 0.92
The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective. Climacteric (2012) 0.91
Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy. Atherosclerosis (2013) 0.90
Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog). Brain Res (2013) 0.89
Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause. J Steroid Biochem Mol Biol (2013) 0.89
Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes. Atherosclerosis (2007) 0.88
Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women. J Clin Endocrinol Metab (2009) 0.88
Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women. Menopause (2010) 0.87
Subclinical atherosclerosis is weakly associated with lower cognitive function in healthy hyperhomocysteinemic adults without clinical cardiovascular disease. Int J Geriatr Psychiatry (2009) 0.87
Vascular effects of estrogenic menopausal hormone therapy. Rev Recent Clin Trials (2012) 0.85
Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg (2008) 0.84
The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition. J Alzheimers Dis (2014) 0.84
Effectiveness of compounded bioidentical hormone replacement therapy: an observational cohort study. BMC Womens Health (2011) 0.84
Birth weight and carotid artery intima-media thickness. J Pediatr (2012) 0.84
The association between soy nut consumption and decreased menopausal symptoms. J Womens Health (Larchmt) (2007) 0.84
Estradiol stimulates capillary formation by human endothelial progenitor cells: role of estrogen receptor-{alpha}/{beta}, heme oxygenase 1, and tyrosine kinase. Hypertension (2010) 0.84
Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes. Menopause (2011) 0.83
Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause. Biol Sex Differ (2013) 0.83
Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril (2013) 0.83
Effect of menopausal status on carotid intima-media thickness and presence of carotid plaque in Chinese women generation population. Sci Rep (2015) 0.82
Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One (2013) 0.82
Estrogens, episodic memory, and Alzheimer's disease: a critical update. Semin Reprod Med (2009) 0.82
Replication of RYR3 gene polymorphism association with cIMT among HIV-infected whites. AIDS (2012) 0.81
Associations of cardiovascular variables and HAART with cognition in middle-aged HIV-infected and uninfected women. J Neurovirol (2011) 0.81
Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance. PLoS One (2013) 0.80
Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease. Cardiovasc Hematol Agents Med Chem (2010) 0.80
Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study. Physiol Genomics (2015) 0.80
Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles. Platelets (2015) 0.80
Prenatal Air Pollution Exposure and Early Cardiovascular Phenotypes in Young Adults. PLoS One (2016) 0.80
Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets. Physiol Rep (2014) 0.79
Improvements of insulin resistance in ovariectomized rats by a novel phytoestrogen from Curcuma comosa Roxb. BMC Complement Altern Med (2012) 0.79
Hormone Replacement Therapy for Primary and Secondary Prevention of Heart Disease. Curr Treat Options Cardiovasc Med (2003) 0.79
Ischemic postconditioning does not provide cardioprotection from long-term ischemic injury in isolated male or female rat hearts. J Surg Res (2010) 0.79
Association of Age at Menopause With Incident Heart Failure: A Prospective Cohort Study and Meta-Analysis. J Am Heart Assoc (2016) 0.79
The role of carotid intima-media thickness in predicting longitudinal cognitive function in an older adult cohort. Cerebrovasc Dis (2014) 0.79
In Perspective: Estrogen Therapy Proves to Safely and Effectively Reduce Total Mortality and Coronary Heart Disease in Recently Postmenopausal Women. Menopause Manag (2008) 0.78
Echolucency of the carotid artery intima-media complex and intima-media thickness have different cardiovascular risk factor relationships: the Women's Interagency HIV Study. J Am Heart Assoc (2015) 0.78
Timing of estrogen replacement influences atherosclerosis progression and plaque leukocyte populations in ApoE-/- mice. Atherosclerosis (2008) 0.78
Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond) (2016) 0.78
The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset? Metabolism (2016) 0.77
Albuminuria as a marker of cardiovascular risk in HIV-infected individuals receiving stable antiretroviral therapy. Hawaii J Med Public Health (2013) 0.77
Post menopausal hormones and measures of subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. Prev Med (2007) 0.77
Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular disease. J Womens Health (Larchmt) (2014) 0.77
Specific cell-derived microvesicles: Linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women. Atherosclerosis (2015) 0.77
G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity. J Endocrinol (2015) 0.76
Prenatal Air Pollution Exposures, DNA Methyl Transferase Genotypes, and Associations with Newborn LINE1 and Alu Methylation and Childhood Blood Pressure and Carotid Intima-Media Thickness in the Children's Health Study. Environ Health Perspect (2016) 0.76
Physical activity and sex hormone levels in estradiol- and placebo-treated postmenopausal women. Menopause (2011) 0.76
Inverse association of serum vitamin D in relation to carotid intima-media thickness in Chinese postmenopausal women. PLoS One (2015) 0.76
Carotid Intima-media Thickness Measurements: Relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled Trials. Chin Med J (Engl) (2016) 0.76
Clinical opinion: the biologic and pharmacologic principles for age-adjusted long-term estrogen therapy. MedGenMed (2006) 0.76
Hormone replacement therapy and heart disease: the remains of the oestrogen hypothesis. Neth Heart J (2003) 0.75
Sex hormone therapy and progression of cardiovascular disease in menopausal women. Clin Sci (Lond) (2016) 0.75
Hormone replacement therapy after the menopause--where are we now? Br J Gen Pract (2005) 0.75
Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy? Vasc Health Risk Manag (2005) 0.75
Effect of statins on estrogen and androgen levels in postmenopausal women treated with estradiol. Climacteric (2010) 0.75
Increased glucose transporter-1 EXPRESSION on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease. AIDS (2016) 0.75
Effect of Half-dose and Standard-dose Conjugated Equine Estrogens Combined with Natural Progesterone or Dydrogesterone on Components of Metabolic Syndrome in Healthy Postmenopausal Women: A Randomized Controlled Trial. Chin Med J (Engl) (2016) 0.75
Sick sinus syndrome associated with hypopituitarism: a case report and literature review. J Biomed Res (2014) 0.75
The Atherosclerosis Risk in Young Adults (ARYA) study: rationale and design. Eur J Epidemiol (2003) 0.75
Brachial artery vasoreactivity is associated with cross-sectional and longitudinal anatomical measures of atherosclerosis in postmenopausal women with coronary artery disease. Atherosclerosis (2007) 0.75
Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA (1987) 5.82
The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med (1998) 4.92
Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol (1997) 3.99
Pregnancy after age 50: application of oocyte donation to women after natural menopause. Lancet (1993) 3.60
Occupational therapy for independent-living older adults. A randomized controlled trial. JAMA (1997) 3.47
Oxidants as stimulators of signal transduction. Free Radic Biol Med (1997) 3.43
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest (1990) 3.40
Does prayer influence the success of in vitro fertilization-embryo transfer? Report of a masked, randomized trial. J Reprod Med (2001) 3.29
Spontaneous coronary dissection: a cluster of cases with this rare finding. Am Heart J (1994) 3.03
Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol (2000) 2.99
Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology (1997) 2.94
Ethnicity and attitudes towards life sustaining technology. Soc Sci Med (1999) 2.93
Longitudinal volumetric MRI change and rate of cognitive decline. Neurology (2005) 2.90
Improved common carotid elasticity and intima-media thickness measurements from computer analysis of sequential ultrasound frames. Atherosclerosis (2001) 2.70
Direct ostioplasty of the left main coronary artery for isolated nonarteriosclerotic ostial stenosis. J Thorac Cardiovasc Surg (1992) 2.61
Reliability of goniometric measurements. Phys Ther (1978) 2.52
Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis (1994) 2.50
Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group. Ophthalmology (1997) 2.49
Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol (1997) 2.42
Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. JAMA (1990) 2.36
Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology (2002) 2.35
Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA (1992) 2.29
Scoliosis: A prospective epidemiological study. J Bone Joint Surg Am (1975) 2.22
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res (2000) 2.22
Normal range of motion of joints in male subjects. J Bone Joint Surg Am (1979) 2.14
MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology (2001) 2.11
Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05
The effects of silicone oil removal. Silicone Study Report 6. Arch Ophthalmol (1994) 2.05
Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation (1993) 2.04
A new technique for right heart catheterization with a Swan-Ganz balloon catheter via femoral vein in the patient with dilated right heart chambers, utilizing a modified transseptal-type sheath. Cathet Cardiovasc Diagn (1991) 2.01
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric (2013) 1.94
Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J (1986) 1.94
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation (1990) 1.89
Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst (1994) 1.87
Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Contraception (1990) 1.84
Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med (1993) 1.82
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77
A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med (1990) 1.76
Global consensus statement on menopausal hormone therapy. Climacteric (2013) 1.74
Mechanisms and consequences of lipid peroxidation in biological systems. Annu Rev Nutr (1985) 1.71
Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med (1990) 1.71
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest (1995) 1.66
Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis. Ophthalmology (1996) 1.66
Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol (1982) 1.66
Factors affecting embryo implantation after human in vitro fertilization: a hypothesis. Am J Obstet Gynecol (1990) 1.64
The influence of diet on the appearance of new lesions in human coronary arteries. JAMA (1990) 1.63
Menopausal hot flushes and night sweats: where are we now? Climacteric (2011) 1.61
Diagnosis and management of a tuberculous, tuboappendiceal fistula. Am J Obstet Gynecol (1988) 1.60
Effects of colestipol-niacin therapy on human femoral atherosclerosis. Circulation (1991) 1.56
Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. Circulation (1997) 1.55
The influence of phospholipase A2 and glutathione peroxidase on the elimination of membrane lipid peroxides. Arch Biochem Biophys (1983) 1.55
Silicone oil in repair of retinal detachments caused by necrotizing retinitis in HIV infection. Arch Ophthalmol (1995) 1.55
A land use regression model for predicting ambient fine particulate matter across Los Angeles, CA. J Environ Monit (2007) 1.54
Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes. Retina (2001) 1.53
Sensitivity, specificity, and predictive values of screening tests for eye conditions in a clinic-based population. Ophthalmology (1996) 1.52
Underuse and overuse of diagnostic testing for coronary artery disease in patients presenting with new-onset chest pain. Am J Med (1999) 1.51
The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. Fertil Steril (1994) 1.51
A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control (1999) 1.50
Why delay the obvious need for milder forms of ovarian stimulation? Hum Reprod (1997) 1.50
Dietary and other lifestyle factors of women with brain gliomas in Los Angeles County (California, USA) Cancer Causes Control (1997) 1.49
Prevention of vaginal trichomoniasis by compliant use of the female condom. Sex Transm Dis (1993) 1.48
Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric (2011) 1.47
Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy. Neurosurgery (2001) 1.47
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study Report 4. Ophthalmology (1993) 1.43
Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med (1996) 1.43
Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation. Fertil Steril (1995) 1.42
Spontaneous regression of restenosis: an angiographic study. J Am Coll Cardiol (1995) 1.42
Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab (1999) 1.42
Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception (1986) 1.42
Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995. Cancer Causes Control (2000) 1.42
Therapeutic controversy: Estrogen replacement in menopause. J Clin Endocrinol Metab (1996) 1.41
Simultaneous establishment of pregnancies in two ovarian failure patients using one oocyte donor. Fertil Steril (1989) 1.39
Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis (1999) 1.39
Evaluation of an expert system on lymph node pathology. Hum Pathol (1997) 1.38
Hypothesis testing of time-dependent recurrent events. Stat Med (1987) 1.38
Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial. Circulation (1995) 1.38
Embryo implantation after human in vitro fertilization: importance of endometrial receptivity. Fertil Steril (1990) 1.37
Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol (1992) 1.37
Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J Lipid Res (1994) 1.36
Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation (1996) 1.36
Evidence for genetic control of nondisjunction in man. Am J Hum Genet (1980) 1.34
Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes (2000) 1.31
Prognosis in uveal melanoma with extrascleral extension. Arch Ophthalmol (1980) 1.30
Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc Natl Acad Sci U S A (2001) 1.30
Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology (2000) 1.29
A randomized comparison of nonoral estradiol delivery in postmenopausal women. Am J Obstet Gynecol (1988) 1.28